Knockdown of Microtubule Associated Serine/threonine Kinase Like Expression Inhibits Gastric Cancer Cell Growth and Induces Apoptosis by Activation of ERK1/2 and Inactivation of NF-κB Signaling

Abstract

Microtubule-associated serine/threonine kinase (MASTL) functions to regulate chromosome condensation and mitotic progression. Therefore, aberrant MASTL expression is commonly implicated in various human cancers. This study analyzed MASTL expression in gastric cancer vs. adjacent normal tissue for elucidating the association with clinicopathological data from patients. This work was then extended to investigate the effects of MASTL knockdown on tumor cells in vitro. The level of MASTL expression in gastric cancer tissue was assessed from the UALCAN, GEPIA, and Oncomine online databases. Lentivirus carrying MASTL or negative control shRNA was infected into gastric cancer cells. RT-qPCR, Western blotting, cell viability, cell counting, flow cytometric apoptosis and cell cycle, and colony formation assays were performed. MASTL was upregulated in gastric cancer tissue compared to the adjacent normal tissue, and the MASTL expression was associated with advanced tumor stage, Helicobacter pylori infection and histological subtypes. On the other hand, knockdown of MASTL expression significantly reduced tumor cell viability and proliferation, and arrested cell cycle at G₂/M stage but promoted tumor cells to undergo apoptosis. At protein level, knockdown of MASTL expression enhanced levels of cleaved PARP1, cleaved caspase-3, Bax and p-ERK1/2 expression, but downregulated expression levels of BCL-2 and p-NF-κB-p65 protein in AGS and MGC-803 cells. MASTL overexpression in gastric cancer tissue may be associated with gastric cancer development and progression, whereas knockdown of MASTL expression reduces tumor cell proliferation and induces apoptosis. Further study will evaluate MASTL as a potential target of gastric cancer therapeutic strategy.

Keywords

gastric cancer / microtubule-associated serine/threonine kinase / gene expression / shRNA

References

[1] Den HoedCM, KuipersEJ, et al.. Gastric Cancer: How Can We Reduce the Incidence of this Disease?. Curr Gastroenterol Rep, 2016, 18(7): 1-8

[2] ZhongY, JohnsonAJ, ByrdJC, et al.. Targeting Interleukin-2-Inducible T-cell Kinase (ITK) in T-Cell Related Diseases. Postdoc J, 2014, 2(6): 1-11

[3] ChenW, ZhengR, BaadePD, et al.. Cancer statistics in China, 2015. CA Cancer J Clin, 2016, 66(2): 115-132

[4] ChangAH, ParsonnetJ. Role of bacteria in oncogenesis. Clin Microbiol Rev, 2010, 23(4): 837-857

[5] GonzalezCA, SalaN, RokkasT. Gastric cancer: epidemiologic aspects. Helicobacter, 2013, 18(Suppl1): 34-38

[6] PuthawalaK, HadjiangelisN, JacobySC, et al.. Inhibition of integrin alpha(v)beta6, an activator of latent transforming growth factor-beta, prevents radiation-induced lung fibrosis. Am J Respir Crit Care Med, 2008, 177(1): 82-90

[7] OrdituraM, GaliziaG, SforzaV, et al.. Treatment of gastric cancer. World J Gastroenterol, 2014, 20(7): 1635-1649

[8] WadhwaR, TaketaT, SudoK, et al.. Modern oncological approaches to gastric adenocarcinoma. Gastroenterol Clin North Am, 2013, 42(2): 359-369

[9] CastroA, LorcaT. Greatwall kinase at a glance. J Cell Sci, 2018, 131(20): jcs222364

[10] RogersS, McCloyRA, ParkerBL, et al.. MASTL overexpression promotes chromosome instability and metastasis in breast cancer. Oncogene, 2018, 37(33): 4518-4533

[11] YoonYN, ChoeMH, JungKY, et al.. MASTL inhibition promotes mitotic catastrophe through PP2A activation to inhibit cancer growth and radioresistance in breast cancer cells. BMC Cancer, 2018, 18(1): 716

[12] UppadaSB, GowrikumarS, AhmadR, et al.. MASTL induces Colon Cancer progression and Chemoresistance by promoting Wnt/beta-catenin signaling. Mol Cancer, 2018, 17(1): 111

[13] WangL, LuongVQ, GianniniPJ, et al.. Mastl kinase, a promising therapeutic target, promotes cancer recurrence. Oncotarget, 2014, 5(22): 11479-11489

[14] ChandrashekarDS, BashelB, BalasubramanyaSAH, et al.. UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses. Neoplasia, 2017, 19(8): 649-658

[15] TangZ, LiC, KangB, et al.. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res, 2017, 45(W1): W98-W102

[16] MarzecK, BurgessA. The Oncogenic Functions of MASTL Kinase. Front Cell Dev Biol, 2018, 6: 162

[17] CettiE, Di MarcoT, MauroG, et al.. Mitosis perturbation by MASTL depletion impairs the viability of thyroid tumor cells. Cancer Lett, 2018, 442: 362-372

[18] RogersS, FeyD, McCloyRA, et al.. PP1 initiates the dephosphorylation of MASTL, triggering mitotic exit and bistability in human cells. J Cell Sci, 2016, 129(7): 1340-1354

[19] WongPY, MaHT, LeeHJ, et al.. MASTL(Greatwall) regulates DNA damage responses by coordinating mitotic entry after checkpoint recovery and APC/C activation. Sci Rep, 2016, 6: 22230

[20] NagelR, Stigter-VanWM, BuijzeM, et al.. Genome-wide siRNA screen identifies the radiosensitizing effect of downregulation of MASTL and FOXM1 in NSCLC. Mol Cancer Ther, 2015, 14(6): 1434-1444

[21] VeraJ, LartigueL, VigneronS, et al.. Greatwall promotes cell transformation by hyperactivating AKT in human malignancies. eLife, 2015, 4: e10115

[22] DirilMK, BisteauX, KitagawaM, et al.. Loss of the Greatwall Kinase Weakens the Spindle Assembly Checkpoint. PLoS Genet, 2016, 12(9): e1006310

[23] OcasioCA, RajasekaranMB, WalkerS, et al.. A first generation inhibitor of human Greatwall kinase, enabled by structural and functional characterisation of a minimal kinase domain construct. Oncotarget, 2016, 7(44): 71182-71197

[24] RobertsonJD, OrreniusS. Molecular mechanisms of apoptosis induced by cytotoxic chemicals. Crit Rev Toxicol, 2000, 30(5): 609-627

[25] GuicciardiME, GoresGJ. Life and death by death receptors. FASEB J, 2009, 23(6): 1625-1637

[26] GilmoreTD. Introduction to NF-kappaB: players, pathways, perspectives. Oncogene, 2006, 25(51): 6680-6684

[27] PerkinsND. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol, 2007, 8(1): 49-62

[28] DolcetX, LlobetD, PallaresJ, et al.. NF-kB in development and progression of human cancer. Virchows Arch, 2005, 446(5): 475-482

[29] PatelM, HorganPG, McMillanDC, et al.. NF-kappaB pathways in the development and progression of colorectal cancer. Transl Res, 2018, 197: 43-56

[30] DingL, GuH, LanZ, et al.. Downregulation of cyclooxygenase1 stimulates mitochondrial apoptosis through the NFkappaB signaling pathway in colorectal cancer cells. Oncol Rep, 2019, 41(1): 559-569

[31] WangY, BaoX, ZhaoA, et al.. Raddeanin A inhibits growth and induces apoptosis in human colorectal cancer through downregulating the Wnt/beta-catenin and NF-kappaB signaling pathway. Life Sci, 2018, 207: 532-549

[32] ZhaoH, XuJ, WangY, et al.. Knockdown of CEACAM19 suppresses human gastric cancer through inhibition of PI3K/Akt and NF-kappaB. Surg Oncol, 2018, 27(3): 495-502

[33] YangZY, QuY, ZhangQ, et al.. Knockdown of metallopanstimulin-1 inhibits NF-kappaB signaling at different levels: the role of apoptosis induction of gastric cancer cells. Int J Cancer, 2012, 130(12): 2761-2770

[34] SunC, LiC, LiX, et al.. Scutellarin induces apoptosis and autophagy in NSCLC cells through ERK1/2 and AKT Signaling Pathways in vitro and in vivo. J Cancer, 2018, 9(18): 3247-3256

[35] CaoR, MengZ, LiuT, et al.. Decreased TRPM7 inhibits activities and induces apoptosis of bladder cancer cells via ERK1/2 pathway. Oncotarget, 2016, 7(45): 72941-72960

[36] GongB, LiuWW, NieWJ, et al.. MiR-21/RASA1 axis affects malignancy of colon cancer cells via RAS pathways. World J Gastroenterol, 2015, 21(5): 1488-1497

[37] GongB, LiuWW, NieWJ, et al.. Inflammatory cytokine-induced expression of MASTL is involved in hepatocarcinogenesis by regulating cell cycle progression. Oncol Lett, 2019, 17(3): 3163-3172

[38] ZhangQ, LiuW, ZhangHM, et al.. hTFtarget: a comprehensive database for regulations of human transcription factors and their targets. Genomics Proteomics Bioinformatics, 2020, 18(2): 120-128

[39] KummEJ, PagelO, GambaryanS, et al.. The Cell Cycle Checkpoint System MAST(L)-ENSA/ARPP19-PP2A is Targeted by cAMP/PKA and cGMP/PKG in Anucleate Human Platelets. Cells, 2020, 9(2): 472

[40] RenD, FisherLA, ZhaoJ, et al.. Cell Cycle-dependent regulation of greatwall kinase by protein phosphatase 1 and regulatory subunit 3B. J Biol Chem, 2017, 292(24): 10026-10034